Lantheus Holdings Correlations
LNTH Stock | USD 97.71 1.14 1.15% |
The current 90-days correlation between Lantheus Holdings and Neurocrine Biosciences is -0.02 (i.e., Good diversification). The correlation of Lantheus Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Lantheus Holdings Correlation With Market
Significant diversification
The correlation between Lantheus Holdings and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lantheus Holdings and DJI in the same portfolio, assuming nothing else is changed.
Lantheus |
Moving together with Lantheus Stock
Moving against Lantheus Stock
0.76 | EVOK | Evoke Pharma | PairCorr |
0.71 | EVO | Evotec SE ADR | PairCorr |
0.57 | ACB | Aurora Cannabis | PairCorr |
0.47 | VTRS | Viatris | PairCorr |
0.4 | EBS | Emergent Biosolutions | PairCorr |
0.33 | CGC | Canopy Growth Corp | PairCorr |
0.32 | SBFMW | Sunshine Biopharma | PairCorr |
0.31 | FLGC | Flora Growth Corp | PairCorr |
0.46 | RDHL | Redhill Biopharma | PairCorr |
0.45 | YCBD | cbdMD Inc | PairCorr |
0.43 | GELS | Gelteq Limited Ordinary | PairCorr |
0.4 | QNTM | Quantum BioPharma Symbol Change | PairCorr |
0.38 | HROW | Harrow Health | PairCorr |
0.37 | OGI | OrganiGram Holdings | PairCorr |
0.35 | PCRX | Pacira BioSciences, | PairCorr |
0.34 | PAHC | Phibro Animal Health | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lantheus Stock performing well and Lantheus Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lantheus Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NBIX | 1.52 | (0.12) | 0.00 | (0.29) | 0.00 | 2.19 | 23.54 | |||
DCPH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
IRWD | 4.06 | (1.02) | 0.00 | (0.67) | 0.00 | 4.17 | 52.86 | |||
ALKS | 1.32 | 0.23 | 0.19 | 0.46 | 1.24 | 3.78 | 10.24 | |||
AVDL | 2.55 | (0.12) | 0.00 | (0.16) | 0.00 | 5.20 | 31.30 | |||
ANIP | 1.63 | 0.28 | 0.15 | 0.20 | 1.77 | 3.04 | 18.94 | |||
RDY | 1.10 | (0.20) | 0.00 | 8.18 | 0.00 | 1.86 | 8.19 | |||
COLL | 1.74 | 0.04 | 0.04 | 0.06 | 1.93 | 3.47 | 18.67 | |||
PCRX | 2.06 | 0.35 | 0.15 | 0.95 | 2.28 | 4.65 | 16.33 |
Lantheus Holdings Corporate Management
Lee Howe | Chief Officer | Profile | |
Daniel Niedzwiecki | General Officer | Profile | |
Dorothy Barr | Senior Operations | Profile | |
Paul Blanchfield | Chief Officer | Profile | |
Amanda Morgan | Senior Commercial | Profile |